|
|
Article: ADHD med reformulated: An old drug reenters market
- Article from:
- Drug Topics
- Article date:
- March 18, 1996
- Author:
CopyrightCopyright Medical Economics Inc. Mar 18, 1996. Provided by ProQuest LLC. (Hide copyright information)
|
A supplemental NDA for Adderall, a psychostimulant made up of various amphetamine salts, has been approved by the Food & Drug Administration for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) in children. ADHD is a condition that affects up to 3% of children and continues into adulthood in about half of those children.
According to Robert Hunt, M.D., a psychiatrist with the Center for Attention & Hyperactivity Disorders in Nashville, Tenn., the psychostimulants are the major medication treatment for inattention in ADHD. He said these drugs have a long track record: Methylphenidate (Ritalin, Ciba-Geigy) and Dexedrine (dextroamphetamine sulfate, SmithKline Beecham) ...